GICARE PHARMA INC has a total of 11 patent applications. Its first patent ever was published in 2007. It filed its patents most often in Australia, EPO (European Patent Office) and Canada. Its main competitors in its focus markets organic fine chemistry and pharmaceuticals are MYLARI BANAVARA L, KAREUS THERAPEUTICS SA and LABORATORIO CHIMICO INT S P A.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 2 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | Canada | 1 | |
#4 | China | 1 | |
#5 | India | 1 | |
#6 | Republic of Korea | 1 | |
#7 | Mexico | 1 | |
#8 | United States | 1 | |
#9 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Acyclic or carbocyclic compounds | |
#3 | Heterocyclic compounds | |
#4 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Guay Daniel | 9 |
#2 | Bydlinski Gregory | 9 |
#3 | Spassova Nadejda | 9 |
#4 | Ranger Maxime | 9 |
#5 | Lau Cheuk Kun | 9 |
#6 | Cantin Louis-David | 7 |
#7 | Meunier Jean-Francois | 5 |
#8 | Cirino Giuseppe | 2 |
#9 | Caliendo Giuseppe | 2 |
#10 | Cantin Louis David | 2 |
Publication | Filing date | Title |
---|---|---|
CN104254517A | Novel sulfonate-based trimebutine salts |